Arkolith/Insider Trading/ACTU/Form 4

BIOS Actuate Co-Invest I, LP

Director, 10% OwnerACTUATE THERAPEUTICS, INC. (ACTU) · full profile →Form 4 · filed Jun 30, 2025
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2025Buy(P)71K$7.00$500K196K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 27, 2025Buy(P)71K—$071K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-063991) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML